The addition of Australian trial sites is expected to facilitate a significantly greater proportion of the trial costs as being eligible for the R&D tax incentive cash rebate, which should have a material impact on reducing the cash requirements for the conduct of the study.
Very clever boxing
Ann: ATL1102 Revised Plans accelerate reporting of unblinded data, page-19
-
- There are more pages in this discussion • 333 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
